150
Participants
Start Date
October 31, 2004
Study Completion Date
September 30, 2005
Quetiapine
Research Site, Arendal
Research Site, Ålesund
Research Site, Klepp stasjon
Research Site, Kristiansand
Research Site, Nesttun
Research Site, Oslo
Research Site, Ottestad
Lead Sponsor
AstraZeneca
INDUSTRY